THE USE OF PUBLISHED REAL-WORLD EVIDENCE IN HTA: AN ANALYSIS OF THE EVIDENCE BASE OF COMPANY SUBMISSIONS IN 2016 NICE APPRAISALS

被引：0
|
作者：
Van Lier, H. [1 ]
de Boeck, M. [1 ]
Edwards, V [1 ]
Hanekamp, E. [1 ]
Hartog, T. E. [1 ]
Richmond, G. [1 ]
van den Broek, R. [1 ]
机构：
[1] Excerpta Medica, Amsterdam, Netherlands
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.076
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HT8
引用
收藏
页码：A410 / A410
页数：1
相关论文
共 50 条
  • [31] TREATMENT OF PSORIASIS: ANALYSIS OF REAL-WORLD EVIDENCE
    Karbusicka, M.
    Duba, J.
    Kolek, M.
    VALUE IN HEALTH, 2019, 22 : S911 - S912
  • [32] REAL-WORLD EVIDENCE IN MULTIPLE SCLEROSIS (MS): HTA DECISION-MAKING INFLUENCER OR NOT?
    Nanda, S.
    Jindal, S.
    Rohillla, A.
    Mahajan, S.
    Saharia, P.
    VALUE IN HEALTH, 2022, 25 (12) : S344 - S344
  • [33] HOW DOES REAL-WORLD EVIDENCE SUPPORT REGULATORY AND HTA AGENCY ASSESSMENTS AND BEYOND?
    Sam, L.
    Ong, A.
    Mckendrick, J.
    VALUE IN HEALTH, 2024, 27 (12)
  • [34] EVALUATING THE HTA IMPACT OF REAL-WORLD EVIDENCE FROM FORMAL ORPHAN DRUG REGISTRIES
    Bustamante, M. M. D.
    Yang, E.
    Anderson, K.
    VALUE IN HEALTH, 2020, 23 : S347 - S347
  • [35] The Use of Real-World Evidence for Regulatory Decisions in China
    Xu, Jiayue
    Wu, Wenkai
    Zhang, Xia
    Ren, Yan
    Yao, Minghong
    Liu, Mei
    Zou, Kang
    Wang, Wen
    Sun, Xin
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (01) : 82 - 95
  • [36] The use of real-world evidence in European medicines regulation
    Brown, Jeremy P.
    Wing, Kevin
    Evans, Stephen
    Bhaskaran, Krishnan
    Smeeth, Liam
    Douglas, Ian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 205 - 206
  • [37] Use of real-world evidence in translational pharmacology research
    Charveriat, Mathieu
    Darmoni, Stephan J.
    Lafon, Vincent
    Moore, Nicholas
    Bordet, Regis
    Veys, Julien
    Mouthon, Franck
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 (02) : 230 - 236
  • [38] Examining the Use of Real-World Evidence in the Regulatory Process
    Beaulieu-Jones, Brett K.
    Finlayson, Samuel G.
    Yuan, William
    Altman, Russ B.
    Kohane, Isaac S.
    Prasad, Vinay
    Yu, Kun-Hsing
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (04) : 843 - 852
  • [39] EXPLORING THE UNKNOWN: USE OF SENSITIVITY ANALYSIS TO CHARACTERIZE RESIDUAL UNCERTAINTY IN REAL-WORLD EXTERNAL CONTROL ARM EVIDENCE SUBMITTED TO NICE
    Leahy, T.
    Keenan, C.
    Robertshaw, E.
    Mcstravick, M.
    Sammon, C.
    Turner, A.
    VALUE IN HEALTH, 2024, 27 (12)
  • [40] The Use of Real-World Data for Estimating Relative Treatment Effects in NICE Health Technology Assessment Submissions: A Review
    Che, Yoojung
    Duffield, Stephen
    Gomes, Manuel
    PHARMACOECONOMICS, 2025, 43 (02) : 123 - 131
12345